The Least Burdensome Provisions - Activities Related to Implementation
- FDAMA Amendments to the Federal Food, Drug and Cosmetic Act
- Least Burdensome Final Guidance
- IDE and PMA Documents
- 510(k) Documents
- Lessening Regulatory Burden - Related Documents
- CDRH/Industry Collaborative Efforts
- Training Materials
FDAMA added the following two provisions to the Federal Food, Drug, and Cosmetic Act. These two provisions are commonly referred to as the "Least Burdensome Provisions."
Section 513(a)(3)(D)(ii)"Any clinical data, including one or more well-controlled investigations, specified in writing by the Secretary for demonstrating a reasonable assurance of device effectiveness shall be specified as a result of a determination by the Secretary that such data are necessary to establish device effectiveness. The Secretary shall consider, in consultation with the applicant, the least burdensome appropriate means of evaluating device effectiveness that would have a reasonable likelihood of resulting in approval."
Section 513(i)(1)(D)"Whenever the Secretary requests information to demonstrate that devices with differing technological characteristics are substantially equivalent, the Secretary shall only request information that is necessary to making substantial equivalence determinations. In making such requests, the Secretary shall consider the least burdensome means of demonstrating substantial equivalence and request information accordingly."
|Posted||Least Burdensome Final Guidance|
|IDE and PMA Documents|
|Lessening Regulatory Burden - Related Documents|
|CDRH/Industry Collaborative Efforts|